TAMARA ESTEVEZ: Open Payments
NPI 1457828030 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 90 payments from 27 companies in 2025. Trend: 2023 $159 · 2024 $572 · 2025 $2,113
Food & beverage: $2,113
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $362 |
| Daiichi Sankyo Inc. | 11 | $271 |
| ABBVIE INC. | 5 | $191 |
| PFIZER INC. | 6 | $140 |
| AstraZeneca Pharmaceuticals LP | 6 | $128 |
| Eisai Inc. | 7 | $113 |
| TerSera Therapeutics LLC | 4 | $104 |
| GENZYME CORPORATION | 6 | $90 |
| Pharmacosmos Therapeutics Inc. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
Products named: JEMPERLI, ELAHERE, Enhertu, DATROWAY, Lenvima, Zoladex, MONOFERRIC, TIVDAK.
Industry payments across FL — which companies pay providers there.
